Susan Margaret Paul

Title: Susan Margaret Paul: Innovator in Pharmaceutical Chemistry

Introduction

Susan Margaret Paul is a distinguished inventor based in Zurich, Switzerland. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for medical applications. Her work focuses on creating effective treatments for pain and various disorders.

Latest Patents

Susan holds a patent for HCI polymorphs of 3-((2-(dimethylamino)methyl(cyclohex-1-yl)) phenol. This patent describes a crystalline salt of 3-[2-(dimethylamino)methyl(cyclohex-1-yl)]phenol and hydrogen chloride, preferably in a 1:1 composition. The patent includes various crystalline forms of this salt, processes for preparing these forms, pharmaceutical compositions containing them, and their use as pharmacologically active agents in treating or inhibiting pain and other disorders.

Career Highlights

Susan is currently employed at Gruenenthal GmbH, where she continues to advance her research in pharmaceutical innovations. Her expertise in the field has led to the development of important therapeutic agents that have the potential to improve patient outcomes.

Collaborations

Throughout her career, Susan has collaborated with notable colleagues, including Markus Kegel and Andreas Fischer. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical solutions.

Conclusion

Susan Margaret Paul is a prominent figure in pharmaceutical chemistry, with a focus on innovative treatments for pain and disorders. Her contributions through patents and collaborations highlight her commitment to advancing medical science.